Ronald Winowiecki Sells 826 Shares of Perrigo Company PLC (NYSE:PRGO) Stock
Perrigo Company PLC (NYSE:PRGO) CFO Ronald Winowiecki sold 826 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $48.03, for a total transaction of $39,672.78. Following the sale, the chief financial officer now directly owns 6,952 shares in the company, valued at $333,904.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
NYSE:PRGO traded down $1.43 during trading hours on Friday, hitting $46.34. 1,007,879 shares of the stock traded hands, compared to its average volume of 1,325,682. The firm has a 50 day moving average price of $50.38 and a 200 day moving average price of $48.47. The company has a current ratio of 1.92, a quick ratio of 1.39 and a debt-to-equity ratio of 0.54. Perrigo Company PLC has a fifty-two week low of $36.28 and a fifty-two week high of $78.90. The firm has a market cap of $6.48 billion, a price-to-earnings ratio of 10.17, a PEG ratio of 4.79 and a beta of 1.40.
Perrigo (NYSE:PRGO) last announced its earnings results on Thursday, August 8th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.05. Perrigo had a net margin of 1.87% and a return on equity of 9.57%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the previous year, the business earned $1.22 EPS. The company’s revenue was down 3.2% on a year-over-year basis. Research analysts predict that Perrigo Company PLC will post 3.95 EPS for the current year.
PRGO has been the topic of several recent analyst reports. SunTrust Banks boosted their target price on shares of Perrigo to $51.00 and gave the company a “hold” rating in a research note on Monday, May 20th. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 1st. Cantor Fitzgerald cut their target price on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 12th. Finally, Wells Fargo & Co reissued a “hold” rating on shares of Perrigo in a research note on Tuesday, July 2nd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $55.14.
Several hedge funds and other institutional investors have recently bought and sold shares of PRGO. Geode Capital Management LLC lifted its holdings in Perrigo by 12.4% in the fourth quarter. Geode Capital Management LLC now owns 1,687,709 shares of the company’s stock valued at $65,286,000 after acquiring an additional 186,095 shares during the period. Nisa Investment Advisors LLC increased its position in shares of Perrigo by 26.9% in the first quarter. Nisa Investment Advisors LLC now owns 38,885 shares of the company’s stock valued at $1,873,000 after buying an additional 8,244 shares in the last quarter. Oakbrook Investments LLC purchased a new stake in shares of Perrigo in the first quarter valued at approximately $304,000. Investors Research Corp purchased a new stake in shares of Perrigo in the first quarter valued at approximately $118,000. Finally, Brinker Capital Inc. increased its position in shares of Perrigo by 758.1% in the first quarter. Brinker Capital Inc. now owns 47,512 shares of the company’s stock valued at $2,288,000 after buying an additional 41,975 shares in the last quarter. 88.22% of the stock is currently owned by institutional investors and hedge funds.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: Coverage Ratio
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.